BioCentury
ARTICLE | Finance

IPO for evergreen

Arix taps the public markets to deploy its evergreen investment strategy

February 24, 2017 8:15 PM UTC

A year after launching with an initial £52 million ($64.8 million), investment company Arix Bioscience plc (LSE:ARIX) has added £100 million ($125.2 million) to its coffers to support up to 15 direct investments across the life sciences space.

Launched last February as Perceptive Bioscience Investments Ltd., Arix has spent the year deploying part of the £52 million through five direct investments and a stake in Cleveland, Ohio, research accelerator BioMotiv LLC. ...